← Back to search
CHILDREN'S RESEARCH INSTITUTE
Doing business as CHILDRENS RESEARCH INSTITUTE
WASHINGTON, DC, 20010
UnclaimedClaim this profile (free)
Prime contracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | BARDA ACCELERATOR NETWORK 2.0, SPECIAL POPULATIONS HUB - CHILDREN'S NATIONAL | — | $3,552,500 | Jun 15, 2026 | Aug 23, 2024 – Aug 20, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - THE CONTRACTOR SHALL PROVIDE SUPPORT SERVICES FOR THE NHLBI PEDIATRIC MRI DIAGNOSIS AND TREATMENT PROGRAM. | — | $2,560,907 | May 20, 2025 | Oct 1, 2014 – Nov 30, 2017 |
| Prime | Department of Health and Human Services National Institutes of Health | BABYHUG FOLLOW-UP STUDY II | — | $387,525 | Oct 22, 2024 | Jan 10, 2012 – Apr 30, 2018 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
5 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE
EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS
RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE
SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN
CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES (OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT
(EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE
CLINICAL TRIAL). AWD00008169-19 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $211,611 | Jun 3, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE
EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS
RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE
SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN
CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES (OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT
(EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE
CLINICAL TRIAL). AWD00008169-19 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $211,611 | Jun 3, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE
EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS
RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE
SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN
CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES (OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT
(EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE
CLINICAL TRIAL). AWD00008169-19 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $211,611 | Jun 3, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN CLINICAL PROTOCOL AND SITE DEVELOPMENT TELECONFERENCES; COLLECT AND PROVIDE TO UAB CENTRAL UNIT ALL SUPPORTING REGULATORY DOCUMENTS FOR CONDUCTING THE STUDY; COMPLETE NECESSARY TRAINING; PROVIDE IRB DOCUMENTATION TO UAB CENTRAL UNIT; BEGIN, TRACK, AND DOCUMENT PATIENT SCREENING AND ENROLLMENT OF SUBJECTS IN ACCORDANCE WITH THE MOST CURRENT APPROVED PROTOCOL; COMPLETE STUDY REQUIRED CLINICAL PROCEDURES; COMPLETE FINAL CLINICAL STUDY PROCEDURES AND FOLLOW-UP FOR ENROLLED SUBJECTS IN ACCORDANCE WITH THE PROTOCOL; SUBMIT ALL REQUIRED DATA TO UAB; AND COMPLETE FINAL CLOSEOUT ACTIVITIES. 000509734-SC005-WIL-A02 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541712 Parent award performance state: AL Parent award description: IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS View parent award on USAspending | — | $25,750 | Jun 15, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | PARTICIPATE IN CLINICAL PROTOCOL AND SITE DEVELOPMENT TELECONFERENCES; COLLECT AND PROVIDE TO UAB CENTRAL UNIT ALL SUPPORTING REGULATORY DOCUMENTS FOR CONDUCTING THE STUDY; COMPLETE NECESSARY TRAINING; PROVIDE IRB DOCUMENTATION TO UAB CENTRAL UNIT; BEGIN, TRACK, AND DOCUMENT PATIENT SCREENING AND ENROLLMENT OF SUBJECTS IN ACCORDANCE WITH THE MOST CURRENT APPROVED PROTOCOL; COMPLETE STUDY REQUIRED CLINICAL PROCEDURES; COMPLETE FINAL CLINICAL STUDY PROCEDURES AND FOLLOW-UP FOR ENROLLED SUBJECTS IN ACCORDANCE WITH THE PROTOCOL; SUBMIT ALL REQUIRED DATA TO UAB; AND COMPLETE FINAL CLOSEOUT ACTIVITIES. 000509734-005 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541712 Parent award performance state: AL Parent award description: IGF::OT::IGF - TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS View parent award on USAspending | — | $25,500 | Oct 19, 2021 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.